ALIGN TECHNOLOGY INC
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | – | – |
| Stockholders' equity | 4,049 | 100.0 |
| Total capitalization | 4,049 | 100.0 |
71,039,852 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 5 August 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Not tagged in XBRL |
CAPITAL STOCK 12/31/25
| Common shares authorized | 200,000,000 |
| Common shares issued | 71,364,000 |
| Par or stated value per share ($) | 0.0001 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 7/31/26 | 71,039,852 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | – | – |
| 2022 | – | – |
| 2021 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware.
BUSINESS: Classified by the SEC under Standard Industrial Classification 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Large accelerated filer. Principal executive office: 410 North Scottsdale Road, Suite 1300, Tempe, AZ 85288. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 4,035 | 3,999 | 3,862 |
| Cost of revenues | 1,324 | 1,200 | 1,155 |
| Gross profit | 2,711 | 2,799 | 2,707 |
| Research and development | 370 | 364 | 347 |
| Selling, general and administrative | 1,756 | 1,763 | 1,703 |
| Depreciation and amortization | 237 | 145 | 142 |
| Operating income | 546 | 608 | 643 |
| Income before income taxes | 585 | 609 | 641 |
| Income taxes | 175 | 188 | 196 |
| Net income | 410 | 421 | 445 |
| Earned per share, diluted ($) | 5.65 | 5.62 | 5.81 |
| Dividends per share ($) | – | – | – |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 1,095 | 1,044 |
| Receivables, net | 1,102 | 996 |
| Inventories | 226 | 254 |
| Total current assets | 2,617 | 2,492 |
| Property, plant and equipment, net | 1,131 | 1,271 |
| Goodwill | 492 | 443 |
| Total assets | 6,234 | 6,215 |
| Total current liabilities | 1,920 | 2,038 |
| Total liabilities | 2,185 | 2,363 |
| Stockholders' equity | 4,049 | 3,852 |
| Total liabilities and equity | 6,234 | 6,215 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 4,035 | 546 | 410 | 10.2 | 5.65 | – | 593 | 102 | 491 | 6,234 | 2,185 | – | 4,049 | 10.1 | – |
| 12/31/24 | 3,999 | 608 | 421 | 10.5 | 5.62 | – | 738 | 116 | 623 | 6,215 | 2,363 | – | 3,852 | 10.9 | – |
| 12/31/23 | 3,862 | 643 | 445 | 11.5 | 5.81 | – | 786 | 178 | 608 | 6,084 | 2,453 | – | 3,630 | 12.3 | – |
| 12/31/22 | 3,735 | 643 | 362 | 9.7 | 4.61 | – | 569 | 292 | 277 | 5,948 | 2,347 | – | 3,601 | 10.0 | – |
| 12/31/21 | 3,953 | 976 | 772 | 19.5 | 9.69 | – | 1,173 | 401 | 771 | 5,942 | 2,319 | – | 3,623 | 21.3 | – |
| 12/31/20 | 2,472 | 387 | 1,776 | 71.8 | 22.41 | – | 662 | 155 | 507 | 4,830 | 1,596 | – | 3,234 | 54.9 | – |
| 12/31/19 | 2,407 | 542 | 443 | 18.4 | 5.53 | – | 747 | 150 | 598 | 2,501 | 1,155 | – | 1,346 | 32.9 | – |
| 12/31/18 | 1,966 | 467 | 400 | 20.4 | 4.92 | – | 555 | 223 | 331 | 2,052 | 800 | – | 1,253 | 31.9 | – |
| 12/31/17 | 1,473 | 354 | 231 | 15.7 | 2.83 | – | 439 | 196 | 243 | 1,784 | 630 | – | 1,154 | 20.0 | – |
| 12/31/16 | 1,080 | 249 | 190 | 17.6 | 2.33 | – | 248 | 71 | 177 | 1,396 | 401 | – | 999 | 19.0 | – |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
ALIGN TECHNOLOGY INC
CIK 1097149 · EIN 94-3267295
PRINCIPAL OFFICE:
410 North Scottsdale Road, Suite 1300, Tempe, AZ 85288
Tel.: 408-470-1000
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 27 February 2026
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/27/26) · 10-K FY2024 (filed 2/28/25) · 10-K FY2023 (filed 2/28/24) · 10-K FY2022 (filed 2/27/23) · 10-K FY2021 (filed 2/25/22) · 10-K FY2020 (filed 2/26/21) · 10-K FY2019 (filed 2/28/20) · 10-K FY2018 (filed 2/28/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.